Helmy Eltoukhy
Co-Chief Executive Officer, Director · Guardant Health, Inc.
- 2024
- Oct 2, 2026
- 11
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Helmy Eltoukhy files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
- Terilyn J. Monroe - $14.82M in GH purchases and sales in the last 12 months
- Chris Freeman - $13.68M in GH purchases and sales in the last 12 months
- Kumud Kalia - $5.78M in GH purchases and sales in the last 12 months
- John G. Saia - $4.25M in GH purchases and sales in the last 12 months
- Ian T. Clark - $2.99M in GH purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Helmy Eltoukhy?
Helmy Eltoukhy is a corporate insider, tracked as Co-Chief Executive Officer, Director of Guardant Health, Inc. (GH). InsiderAlpha holds 11 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Helmy Eltoukhy submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Helmy Eltoukhy been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($30.47M) across all tracked filings.
